Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 17, 2024
Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics
Miriam Rabl, Christopher Clark, Loïc Dayon, et al.
Frontiers in Aging Neuroscience
|
December 26, 2022
The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease
Christopher Clark, Miriam Rabl, Loïc Dayon, et al.
Alzheimer'S Research & Therapy
|
December 18, 2022
Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Sami Ouanes, Miriam Rabl, Christopher Clark, et al.
Journal of Neurochemistry
|
October 25, 2022
Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people
Miriam Rabl, Christopher Clark, Loïc Dayon, et al.
Journal of Alzheimer'S Disease : JAD
|
December 4, 2025
Omics-AD-A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics
Miriam Rabl, Leonardo Zullo, Jelena Wehrli, et al.
Swiss Medical Weekly
|
March 26, 2025
Conference report: Trends, new technologies and implications for dementia diagnostics, treatment and care in Switzerland
Julius Popp, Reto W Kressig, Mélanie Bieler-Aeschlimann, et al.
European Journal of Neurology
|
March 1, 2025
Cortisol and 10-Year Cognitive Decline in Older People From the General Population
Simone Amendola, Sami Ouanes, Leonardo Zullo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Miriam Rabl, Pyry Helkkula, Willem Lucas Hartog, et al.
Research Square
|
April 2, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Alzheimer'S Research & Therapy
|
July 25, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 17, 2024
Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics
Miriam Rabl, Christopher Clark, Loïc Dayon, et al.
Frontiers in Aging Neuroscience
|
December 26, 2022
The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease
Christopher Clark, Miriam Rabl, Loïc Dayon, et al.
Alzheimer'S Research & Therapy
|
December 18, 2022
Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Sami Ouanes, Miriam Rabl, Christopher Clark, et al.
Journal of Neurochemistry
|
October 25, 2022
Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people
Miriam Rabl, Christopher Clark, Loïc Dayon, et al.
Journal of Alzheimer'S Disease : JAD
|
December 4, 2025
Omics-AD-A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics
Miriam Rabl, Leonardo Zullo, Jelena Wehrli, et al.
Swiss Medical Weekly
|
March 26, 2025
Conference report: Trends, new technologies and implications for dementia diagnostics, treatment and care in Switzerland
Julius Popp, Reto W Kressig, Mélanie Bieler-Aeschlimann, et al.
European Journal of Neurology
|
March 1, 2025
Cortisol and 10-Year Cognitive Decline in Older People From the General Population
Simone Amendola, Sami Ouanes, Leonardo Zullo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Miriam Rabl, Pyry Helkkula, Willem Lucas Hartog, et al.
Research Square
|
April 2, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Alzheimer'S Research & Therapy
|
July 25, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Page
of 2